How to Approach an Increasingly Challenging and Subjective Japanese Pricing Environment Patrick Branch Read more
Related Practice Life Sciences & Pharma Japan remains on balance an attractive pharmaceutical market, with favorable volume dynamics, generally attractive pricing and broad and unfettered market access. 10262020171026
Article Digital AI Has Moved Beyond Hype — It Is Driving Performance and Deployment Is Widespread September 20, 2023
Executive Insights Diagnostics, Tools and Personalized Medicine Creating a Vibrant Ecosystem for Precision Medicine: A Prescription for Success July 6, 2023
Special Report Digital Digital Excellence in Healthcare and Life Sciences: Riding the Wave of Innovation March 30, 2023
Executive Insights Sustainability From Commitment to Reality: Overcoming the Corporate Sustainability Struggle October 4, 2022